Redasoft Launches New Web Site to Help Drive Productivity Improvements in Drug Discovery Research

Vernalis and Roche Cancel Development of Obesity Drug

Guidant Acquires Cook

InvestBio Initiates a Strong Buy Rating on MGI Pharma, Inc. (NASDAQ: MOGN) with a $20 Target

InvestBio Completes Second Round Financing 

Inhibition of angiogenesis as a new treatment modality

Expanding Marketed Drugs into Alzheimer Treatment

Micronic NV. Colour innovation enhances high integrity tube capping system …

Nanosphere Signs Letter of Intent with Takara Bio Inc. to Form Development and Distribution Alliance

Breakthroughs in the treatment of stroke and spinal cord injury on the horizon?

Further proof of concept for targeting ghrelin in the treatment of obesity

Histone deacatylases continue to feature at the cutting edge of oncology

Biowisdom announce membership of distinguished scientific advisory board

Cambridge Biotechnology Ltd (CBT) has secured a £6 million series 'A' financing 

Hurdles to Vevesca Approval

Vardenafil Approvable

Euromobility The Trend for Life Sciences Workforces of the Future?

Oxford Biomedica plc and Arius Research Inc Sign collaborative programme in tumour immunotherapy

Expansion of Statins and NSAIDs to Alzheimer Treatment

Aranesp Label Expanded

Statins for Alzheimer Disease

Memantine for Alzheimer Disease

Eprex Versus Aranesp

Aranesp Label Expanded

Statins for Alzheimer Disease

Memantine for Alzheimer Disease

Eprex Versus Aranesp

InvestBio® Announces Partnership with BioPortfolio

InvestBio® Initiates a Strong Buy Rating on Allos Pharmaceuticals, Inc. (NASDAQ: ALTH) with a $20 Target

Micronic NV. Society for Biomolecular Screening new product

New Amino Acid Analyser AAA for Montreal Children’s Hospital

Increasing sales for Porvair Sciences in 2002 …

BIOWISDOM - DISCOVERYINSIGHT FOR NEUROSCIENCE - ENABLING INVENTION FOR DRUG DISCOVERY 

Cellomics - New HCS Reader at the forefront of drug discovery …

Interactive Voice Response (IVR) Technology Adds Value to Clinical Trials

Genomics Derived Drug Enters Clinical Trials

ALRX - AlphaRx Announces Commercialization of Flexogan Topical Analgesic Products, Utilizing Proprietary Enhanced Proven Drug Delivery Technology

InvestBio® Unveils Three-Tier System to Rate Stocks

Histone deacetylase inhibitors: Redefining pharmaceutical approaches to the treatment of cancer

BTECH WEEKLY REPORT: THALIDOMIDE, STATINS, AND ANGIOMAX

InvestBio Initiates a Strong Buy Rating on Millennium Pharmaceuticals, Inc. (NASDAQ: MLNM) with a $29 Target

InvestBio Announces It Will Be Heard on United Airline’s Sky Radio

InvestBio Announces Its Model Portfolio is on the Rise

InvestBio - Announces Investment Opinion on BioTransplant, Allos Therapeutics, Vaxgen, Inc., MGI Pharma, Inc., and Millennium Pharmaceuticals, Inc.

Diversified Biotech Group, Inc. Featured in Investment News

Diversified Biotech Group, Inc. Introduces InvestBio Website - Promising Research Section

New Nitric Oxide Therapeutics

IGENEON LICENSES HUMANIZED ANTIBODY IN CANCER FROM PROTEIN DESIGN LABS 

IBA establishes US Distribution Center

Capsulution NanoScience AG Federal Research Ministry supports Nanotechnology

Enact Pharma Patent Status Update

NUNC The Art of Cell Culture NUNC Flasks on a Slide

Early Access Program validates LabCD™ technology ...

The next step in liquid handling automation ...

DANIOLABS RAISES £850k IN SEED FUNDING TO ACCELERATE ITS DRUG DISCOVERY PROCESS

Stocktaking after an exceptional year of co-operation with LEO Pharmaceutical Products Ltd. A/S

KREATECH Licenses ULS Technology to PerkinElmer Life Sciences

Alzheimer Disease Therapeutics After Betabloc

BTECH WEEKLY REPORT: EXPANDING INDICATIONS FOR REMICADE AND ENBREL

Slow Release formulation allows pig growth hormone to be effective for 21 days

French Technology Leaders Form Strategic Council for Innovation

Innate Pharma raises Euro 20 million for clinical trials

Completion of flotation on TSX & AIM YM BioScience raises c$15 million (gross)

Autoscribe - Cutting edge Laboratory Information Management

IBA: Functionally isolating T-cells

AlphaRX Announces Commercialization of LipoBloc(TM) and LipoLette(TM)

InFUSE Bone Graft Approved

NUNC Silent Screen Plates

Cambridge Biotechnology Consultancy Takes Lead Role at Australian Biotechnology Conference

New Trials for Insomnia, Diabetes, and Crohn Disease